Milestone Scientific Inc. (MLSS)

NYSEAMERICAN: MLSS · IEX Real-Time Price · USD
0.570
+0.011 (1.97%)
Apr 25, 2024, 3:59 PM EDT - Market closed
1.97%
Market Cap 43.66M
Revenue (ttm) 9.83M
Net Income (ttm) -6.93M
Shares Out 76.60M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 221,817
Open 0.542
Previous Close 0.559
Day's Range 0.537 - 0.610
52-Week Range 0.520 - 1.350
Beta 0.94
Analysts n/a
Price Target n/a
Earnings Date May 9, 2024

About MLSS

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug... [Read more]

Sector Healthcare
IPO Date Nov 3, 1995
Employees 17
Stock Exchange NYSEAMERICAN
Ticker Symbol MLSS
Full Company Profile

Financial Performance

In 2023, MLSS's revenue was $9.83 million, an increase of 11.60% compared to the previous year's $8.81 million. Losses were -$6.93 million, -20.41% less than in 2022.

Financial Statements

News

Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023

Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technology Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technolog...

24 days ago - GlobeNewsWire

Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call

ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t...

4 weeks ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians

Follows successful evaluation by Omaha Pain Physicians' founder and medical director, Dr. Matthew Stottle, reporting 100% success Follows successful evaluation by Omaha Pain Physicians' founder and me...

6 weeks ago - GlobeNewsWire

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio

ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

2 months ago - GlobeNewsWire

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast

ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

2 months ago - GlobeNewsWire

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

Reports initial reimbursements of CompuFlo® by commercial payors and Medicare Reports initial reimbursements of CompuFlo® by commercial payors and Medicare

3 months ago - GlobeNewsWire

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

4 months ago - GlobeNewsWire

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

ROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

4 months ago - GlobeNewsWire

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

4 months ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Adoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success

4 months ago - GlobeNewsWire

Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain

ROSELAND, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

5 months ago - GlobeNewsWire

Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023

Reports 45% increase in domestic sales for the third quarter of 2023; new online store providing greater interaction with dentists and improved margins

5 months ago - GlobeNewsWire

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to...

5 months ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York

Represents first sales by the Company into an ambulatory surgery center Follows successful evaluation by Island Ambulatory Surgery Center's founder and medical director, Dr. Leon Reyfman, reporting 10...

6 months ago - GlobeNewsWire

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

ROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, t...

8 months ago - GlobeNewsWire

Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023

Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and improved margins Medical division reports positive reimbursement from...

9 months ago - GlobeNewsWire

Milestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to...

9 months ago - GlobeNewsWire

Milestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural System

ROSELAND, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today a...

9 months ago - GlobeNewsWire

Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th

ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today a...

11 months ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

Follows successful evaluation by Dr. Fabian Proano, MD including complex thoracic procedures Follows successful evaluation by Dr. Fabian Proano, MD including complex thoracic procedures

1 year ago - GlobeNewsWire

Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023

ROSELAND, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

1 year ago - GlobeNewsWire

Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery

ROSELAND, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, as ...

1 year ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon

Follows successful evaluation by Dr. Jimmy D. Huebert, MD, including Epidural Steroid Injection (ESI) procedures in lumbar, thoracic and cervical thoracic junction of the spine Follows successful eval...

1 year ago - GlobeNewsWire

Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, tod...

1 year ago - GlobeNewsWire

Milestone Scientific Provides 2022 Year-End Business Update

ROSELAND, N.J., March 31, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, t...

1 year ago - GlobeNewsWire